RISK FACTORS AND TREATMENT APPROACHES FOR URINARY TRACT INFECTIONS CAUSED BY COMMUNITY AND HOSPITAL ACQUIRED EXTENDED SPECTRUM BETA-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE

Basit Öğe Kaydı
dc.contributor.authorKaradogan, Eda
dc.contributor.authorSumer, Sua
dc.contributor.authorDemir, Nazlim Aktug
dc.contributor.authorUral, Onur
dc.date.accessioned2020-03-26T19:26:07Z
dc.date.available2020-03-26T19:26:07Z
dc.date.issued2016
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractObjective: In recent years, extended-spectrum beta-lactamase (ESBL) producing microorganisms are responsible not only for healthcare-associated but also for community-acquired urinary tract infections (UTI). The aim of this study is to evaluate the risk factors of community acquired and healthcare associated UTI caused by ESBL producing Escherichia coli and Klebsiella pneumoniae and treatment options in outpatients and inpatients. Material and Method: In this study 200 patients with UTI caused by ESBL producing E.coli and K.pneumoniae followed up between 1 January 2012 and 31 December 2013 at Selcuk University Faculty of Medicine Hospital were evaluated with file review. Results: Compared to community-acquired UTI presence of underlying disease, previous antibiotic use, urinary catheterization, hospital admission in the last 6 months were more common in healthcare associated infection When inpatient treatment was evaluated imipenem was more commonly used in healthcare associated infections and when outpatient treatment was evaluated the combination of nitrofurantoin and fosfomycin was more commonly used in community acquired infections. Conclusion: The presence of underlying disease, history of antibiotic use in the past month, hospital admission in the last 6 months and urinary catheterization were highlights in healthcare associated UTI caused by ESBL producing microorganisms. Carbapenems were seen the first choice in the treatment of these infections. According to clinical and laboratory findings, combination of nitrofurantoin and fosfomycin was seen to be o good alternative for treatment of outpatients with UTI caused by ESBL producing E.coli and K.pneumoniae.en_US
dc.identifier.endpage72en_US
dc.identifier.issn1305-2381en_US
dc.identifier.issue3en_US
dc.identifier.pmid#YOKen_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage67en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/33958
dc.identifier.volume12en_US
dc.identifier.wosWOS:000391179400010en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherNOBEL ILACen_US
dc.relation.ispartofNOBEL MEDICUSen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectNosocomialen_US
dc.subjectcommunity acquireden_US
dc.subjectESBLen_US
dc.subjectE.colien_US
dc.subjectK.pneumoniaeen_US
dc.titleRISK FACTORS AND TREATMENT APPROACHES FOR URINARY TRACT INFECTIONS CAUSED BY COMMUNITY AND HOSPITAL ACQUIRED EXTENDED SPECTRUM BETA-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAEen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu